parent-child interaction within an inpatient setting (psychiatric hospital) F32 F40.1 F43.1 F43.2 F90.0 F91 F93 F94.1 F94.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants in both groups will be children age 4-12 years old that present with a range of emotional and behavioral problems. Participants will be exclusively patients admitted to the inpatient-ward “Kaleidoskop”. The age group will be restricted to the range from 4-12 years for reasons of statistical matching and data analysis (one part of the ward only includes patients 4-12 years). Excluded will be therefore children younger than 4years or older than 12 years. A prior diagnosis is not required for admission to the study. This is due to the fact that diagnoses and interdisciplinary diagnostics usually happens throughout the inpatient treatment and are thereby subject to adaptation. However, all children enrolled in this study will have received a preliminary or temporary diagnosis upon admission to the ward. Children that are not living with their primary caregivers (e.g. foster home) will be excluded from the study as well as children with severe intellectual disabilities. Children that have experienced severe trauma, induced by their primary caregiver will be excluded for ethical considerations. Children with an acute psychiatric disorder (e.g. psychosis) will not be included in this study. Inclusion and exclusion criteria parents Parents that are admitted to the ward with their children are usually the primary caregivers of the child, although from experience, they are mostly mothers (about 60:40 ratio mothers vs. fathers). However, both fathers and mothers that are admitted with their child will be included in this study. Gender of the parent will be included in data analysis. Parents of children participating in this study will receive information about aims and structure of this project prior to participating. Informed consent will be obtained prior to participation. Parents have the right to refuse participation in the study prior to start of the treatment. This will be in written format. Additionally, a verbal information session about the study purposes will be conducted prior to participation Although caregivers are not regarded as primary participants in this project, by nature, they are often an important part in aetiological considerations of a patients’ disease model. In addition, parents with a mental illness themselves pose a well-known risk factor for the child’s psychopathology (e.g. Mattejat & Remschmidt, 2008). For that reason, parents will receive a screening questionnaire (Symptom-Checklist-90-Standard; SCL-90-S) upon admission and release of the child (Derogatis & Fitzpatrick, 2004). Parents will also be asked about any psychiatric diagnoses they may have received in the past. Parents with an acute psychiatric disorder (e.g. psychosis) will be excluded from the study.
Exclusion criteria
Exclusion criteria: Inclusion and exclusion criteria parents Parents that are admitted to the ward with their children are usually the primary caregivers of the child, although from experience, they are mostly mothers (about 60:40 ratio mothers vs. fathers). However, both fathers and mothers that are admitted with their child will be included in this study. Gender of the parent will be included in data analysis. Parents of children participating in this study will receive information about aims and structure of this project prior to participating. Informed consent will be obtained prior to participation. Parents have the right to refuse participation in the study prior to start of the treatment. This will be in written format. Additionally, a verbal information session about the study purposes will be conducted prior to participation Although caregivers are not regarded as primary participants in this project, by nature, they are often an important part in aetiological considerations of a patients’ disease model. In addition, parents with a mental illness themselves pose a well-known risk factor for the child’s psychopathology (e.g. Mattejat & Remschmidt, 2008). For that reason, parents will receive a screening questionnaire (Symptom-Checklist-90-Standard; SCL-90-S) upon admission and release of the child (Derogatis & Fitzpatrick, 2004). Parents will also be asked about any psychiatric diagnoses they may have received in the past. Parents with an acute psychiatric disorder (e.g. psychosis) will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome parameter in relation to primary hypothesis will be defined as improvement in parent-child interaction (measured via score on the H-MIM) and symptom reduction (measured via score on the CBCL). Both parameters will be measured at the beginning of therapy (within first 3 days of admission) and at cut-off point at 5 weeks. In relation to hypothesis (ii), heart rate variability will be measured at 4 time points. 2 time points (pre- and post) will be in relation to the initial interaction task (within the first 3 days of admission). The other 2 time points (pre- and post) will be at cut-off after 5 weeks of therapy. In relation to hypothesis (iii), SBKJ-P questionnaire will be carried out at 3 time-points (after 2, 4 and 5 weeks). This questionnaire relates to the mechanisms of therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Parent-psychopathology (measured via the SCL-90-S) will be considered as a secondary outcome parameter and will be assessed upon admission (pre-test). Parent-psychopathology will be assumed to potentially impact primary outcome parameters. | — |
Countries
Germany
Contacts
Psychologist at Helios-Klinikum Berlin-Buch